Followers | 42 |
Posts | 5751 |
Boards Moderated | 0 |
Alias Born | 04/12/2021 |
Monday, July 18, 2022 6:18:54 AM
Why Biofrontera Stock Is Surging Today
Biofrontera Inc (NASDAQ: BFRI) shares are trading significantly higher Wednesday after the company announced it received U.S. Food and Drug Administration approval for its cGMP laboratory in Germany.
The FDA has approved Biofrontera's German laboratory as a contract lab for batch control and stability testing of Ameluz. This recognition enables significant improvements in product manufacturing efficiency, quality control and reliability of supply.
The clearance will allow part of the necessary testing of production batches to be performed in the company's Germany-based facility, thereby reducing dependence on third-party suppliers and the risk of production downtime and product delays.
Biofrontera is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions.
BFRI 52-Week Range: $2.20 - $14.63
According to data from Benzinga Pro, the stock was up 42.3% at $5.27 at time of publication.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
Since 4/13 - has closed six times below the lower bollinger band on the 3 month chart without closing above the upper bollinger band, earnings yoy expected up 30%, 10 million shares traded the last 5 days, is Armistice capital done selling ? The chart is overdue for a major increase, let’s have some sort of product communication before open that energizes this shareprice. 18.95 million O/S, would be a missed chart opportunity imo if nothing is promoted. BFRI was at 5.27 a share based on that news, so factoring in interest rate increases as priced in already why is this stock at an all time low, nothing else changed other than reporting the best first half revenue ever recorded. BFRI is 75% less valuable today than 3 months ago based on what metric.
my posts are always theory and not financial advice
Recent BFRI News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:49:13 PM
- Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 08/14/2024 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:15:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:10 PM
- Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/08/2024 10:14:05 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 03/05/2024 10:20:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 02:26:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 02:37:27 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 02/20/2024 12:55:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 10:25:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:30:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:40:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/09/2024 10:01:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:27:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 10:25:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 10:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 10:00:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:30:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/17/2023 11:02:22 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM